Abstract

BackgroundViral vectors are invaluable tools to transfer genes and/or regulatory sequences into differentiated cells such as pancreatic cells. To date, several kinds of viral vectors have been used to transduce different pancreatic cell types, including insulin-producing β cells. However, few studies have used vectors derived from « simple » retroviruses, such as avian α- or mouse γ-retroviruses, despite their high experimental convenience. Moreover, such vectors were never designed to specifically target transgene expression into β cells.ResultsWe here describe two novel α- or SIN (Self-Inactivating) γ-retrovectors containing the RIP (Rat Insulin Promoter) as internal promoter. These two retrovectors are easily produced in standard BSL2 conditions, rapidly concentrated if needed, and harbor a large multiple cloning site. For the SIN γ-retrovector, either the VSV-G (pantropic) or the retroviral ecotropic (rodent specific) envelope was used. For the α-retrovector, we used the A type envelope, as its receptor, termed TVA, is only naturally present in avian cells and can efficiently be provided to mammalian β cells through either exogenous expression upon cDNA transfer or gesicle-mediated delivery of the protein. As expected, the transgenes cloned into the two RIP-containing retrovectors displayed a strong preferential expression in β over non-β cells compared to transgenes cloned in their non-RIP (CMV- or LTR-) regulated counterparts. We further show that RIP activity of both retrovectors mirrored fluctuations affecting endogenous INSULIN gene expression in human β cells. Finally, both α- and SIN γ-retrovectors were extremely poorly mobilized by the BXV1 xenotropic retrovirus, a common invader of human cells grown in immunodeficient mice, and, most notably, of human β cell lines.ConclusionOur novel α- and SIN γ-retrovectors are safe and convenient tools to stably and specifically express transgene(s) in mammalian β cells. Moreover, they both reproduce some regulatory patterns affecting INSULIN gene expression. Thus, they provide a helpful tool to both study the genetic control of β cell function and monitor changes in their differentiation status.

Highlights

  • Viral vectors are invaluable tools to transfer genes and/or regulatory sequences into differentiated cells such as pancreatic cells

  • Once retro-transcribed and integrated, the vector transcription is driven by its intact 5′ long terminal repeat (LTR), which displays a fairly ubiquitous expression

  • The SF internal promoter (U3 region of SFFV LTR, Spleen Focus Forming Virus LTR), which is active in most cells, was replaced by the 405 bp Rat Insulin Promoter (RIP) promoter [6, 10]

Read more

Summary

Introduction

Viral vectors are invaluable tools to transfer genes and/or regulatory sequences into differentiated cells such as pancreatic cells. The most widely used viral vectors to transduce pancreatic cells are based on either adenoviruses, adeno-associated viruses or lentiviruses (generally HIV1, Human Immunodeficiency Virus-1) These viral vectors provide efficient tools that allow successful and even specific gene expression in different pancreatic exocrine or endocrine sub-populations, including insulinproducing β cells [6,7,8, 10,11,12,13]. We used the well known α − and γ- « simple » retroviruses as backbones and describe here two new α − and SIN (Self-Inactivating) γretrovectors respectively based on ASLV(A) (Avian Sarcoma and Leukosis Virus subgroup A) and MLV (Murine Leukemia Virus) retroviruses Both harbor the RIP (Rat Insulin Promoter) as internal (transgene regulating) promoter. In both retroviral contexts, the RIP activity is much stronger in β cells than in nonβ cells and displays fluctuations that parallel those affecting the endogenous INSULIN gene expression

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call